Refine Search

New Search

Result: 1

(searched for: doi:10.3390/ijns6040085)
Save to Scifeed
Page of 1
Articles per Page
by
Show export options
  Select all
International Journal of Neonatal Screening, Volume 6; doi:10.3390/ijns6040091

Abstract:
There have been significant advances allowing for the integration of mucopolysaccharidosis I into newborn screening programs. Initial experiences using a single-tier approach for this disorder have highlighted shortcomings that require immediate remediation. The recent evaluation of a second-tier biomarker integrated into the MPS I newborn screening protocol has been demonstrated to greatly improve the precision and predictive value of newborn screening for this disorder. This commentary urges newborn screening programs to learn from these experiences and improve newborn screening for mucopolysaccharidosis I and future mucopolysaccharidoses newborn screening programs by implementation of a second-tier biomarker analyte.
Page of 1
Articles per Page
by
Show export options
  Select all
Back to Top Top